nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—L-Phenylalanine—Melphalan—peripheral nervous system neoplasm	0.382	1	CrCrCtD
Nateglinide—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0717	0.15	CbGbCtD
Nateglinide—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0717	0.15	CbGbCtD
Nateglinide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0538	0.113	CbGbCtD
Nateglinide—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0377	0.079	CbGbCtD
Nateglinide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.036	0.0756	CbGbCtD
Nateglinide—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0329	0.069	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0329	0.069	CbGbCtD
Nateglinide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0247	0.0518	CbGbCtD
Nateglinide—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0226	0.0474	CbGbCtD
Nateglinide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0225	0.0473	CbGbCtD
Nateglinide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.021	0.044	CbGbCtD
Nateglinide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0154	0.0324	CbGbCtD
Nateglinide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00962	0.0202	CbGbCtD
Nateglinide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00946	0.0198	CbGbCtD
Nateglinide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00882	0.0185	CbGbCtD
Nateglinide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00602	0.0126	CbGbCtD
Nateglinide—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00384	0.727	CbGdCrCtD
Nateglinide—L-Phenylalanine—TH—peripheral nervous system neoplasm	0.00202	0.402	CrCbGaD
Nateglinide—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00144	0.272	CbGdCrCtD
Nateglinide—Ramipril—BCHE—peripheral nervous system neoplasm	0.00143	0.284	CrCbGaD
Nateglinide—Osteoarthritis—Alitretinoin—peripheral nervous system neoplasm	0.00096	0.00771	CcSEcCtD
Nateglinide—Neuropathy peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000957	0.00769	CcSEcCtD
Nateglinide—Neuropathy peripheral—Tretinoin—peripheral nervous system neoplasm	0.000957	0.00769	CcSEcCtD
Nateglinide—Neuropathy peripheral—Melphalan—peripheral nervous system neoplasm	0.000944	0.00759	CcSEcCtD
Nateglinide—Sweating—Topotecan—peripheral nervous system neoplasm	0.000943	0.00758	CcSEcCtD
Nateglinide—Jaundice—Melphalan—peripheral nervous system neoplasm	0.000939	0.00755	CcSEcCtD
Nateglinide—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.000936	0.00752	CcSEcCtD
Nateglinide—Sweating—Tretinoin—peripheral nervous system neoplasm	0.000936	0.00752	CcSEcCtD
Nateglinide—Polyuria—Cisplatin—peripheral nervous system neoplasm	0.000931	0.00748	CcSEcCtD
Nateglinide—Hepatobiliary disease—Topotecan—peripheral nervous system neoplasm	0.00093	0.00748	CcSEcCtD
Nateglinide—Hepatobiliary disease—Melphalan—peripheral nervous system neoplasm	0.000911	0.00732	CcSEcCtD
Nateglinide—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.000863	0.00694	CcSEcCtD
Nateglinide—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.00694	CcSEcCtD
Nateglinide—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.000828	0.00666	CcSEcCtD
Nateglinide—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.000828	0.00666	CcSEcCtD
Nateglinide—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.000808	0.00649	CcSEcCtD
Nateglinide—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000798	0.00641	CcSEcCtD
Nateglinide—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000781	0.00628	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.000771	0.0062	CcSEcCtD
Nateglinide—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.000769	0.00618	CcSEcCtD
Nateglinide—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.000763	0.00613	CcSEcCtD
Nateglinide—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.00613	CcSEcCtD
Nateglinide—Back pain—Topotecan—peripheral nervous system neoplasm	0.000744	0.00598	CcSEcCtD
Nateglinide—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.000738	0.00593	CcSEcCtD
Nateglinide—Back pain—Tretinoin—peripheral nervous system neoplasm	0.000738	0.00593	CcSEcCtD
Nateglinide—Neuropathy peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.00583	CcSEcCtD
Nateglinide—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000715	0.00574	CcSEcCtD
Nateglinide—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000715	0.00574	CcSEcCtD
Nateglinide—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000709	0.0057	CcSEcCtD
Nateglinide—Neuropathy peripheral—Vincristine—peripheral nervous system neoplasm	0.000699	0.00561	CcSEcCtD
Nateglinide—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.000688	0.00553	CcSEcCtD
Nateglinide—Sweating—Vincristine—peripheral nervous system neoplasm	0.000683	0.00549	CcSEcCtD
Nateglinide—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.000677	0.00544	CcSEcCtD
Nateglinide—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000674	0.00542	CcSEcCtD
Nateglinide—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000674	0.00542	CcSEcCtD
Nateglinide—Cough—Topotecan—peripheral nervous system neoplasm	0.000671	0.00539	CcSEcCtD
Nateglinide—Cough—Tretinoin—peripheral nervous system neoplasm	0.000666	0.00535	CcSEcCtD
Nateglinide—Cough—Isotretinoin—peripheral nervous system neoplasm	0.000666	0.00535	CcSEcCtD
Nateglinide—Cough—Melphalan—peripheral nervous system neoplasm	0.000657	0.00528	CcSEcCtD
Nateglinide—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00526	CcSEcCtD
Nateglinide—Arthropathy—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00511	CcSEcCtD
Nateglinide—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.000631	0.00507	CcSEcCtD
Nateglinide—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.00505	CcSEcCtD
Nateglinide—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.000618	0.00496	CcSEcCtD
Nateglinide—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000607	0.00488	CcSEcCtD
Nateglinide—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000602	0.00484	CcSEcCtD
Nateglinide—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000602	0.00484	CcSEcCtD
Nateglinide—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000596	0.00479	CcSEcCtD
Nateglinide—Arthropathy—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.00473	CcSEcCtD
Nateglinide—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00465	CcSEcCtD
Nateglinide—Lisinopril—ABCB1—peripheral nervous system neoplasm	0.000577	0.115	CrCbGaD
Nateglinide—Cilazapril—ABCB1—peripheral nervous system neoplasm	0.000577	0.115	CrCbGaD
Nateglinide—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.000566	0.00455	CcSEcCtD
Nateglinide—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000563	0.00452	CcSEcCtD
Nateglinide—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00449	CcSEcCtD
Nateglinide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000552	0.00444	CcSEcCtD
Nateglinide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000548	0.0044	CcSEcCtD
Nateglinide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000548	0.0044	CcSEcCtD
Nateglinide—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000546	0.00439	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000542	0.00435	CcSEcCtD
Nateglinide—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000542	0.00435	CcSEcCtD
Nateglinide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000541	0.00435	CcSEcCtD
Nateglinide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000541	0.00435	CcSEcCtD
Nateglinide—Back pain—Vincristine—peripheral nervous system neoplasm	0.000539	0.00433	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000537	0.00432	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000537	0.00432	CcSEcCtD
Nateglinide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000537	0.00431	CcSEcCtD
Nateglinide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000537	0.00431	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00053	0.00426	CcSEcCtD
Nateglinide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00053	0.00426	CcSEcCtD
Nateglinide—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000513	0.00412	CcSEcCtD
Nateglinide—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000511	0.00411	CcSEcCtD
Nateglinide—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000511	0.00411	CcSEcCtD
Nateglinide—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000509	0.00409	CcSEcCtD
Nateglinide—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000509	0.00409	CcSEcCtD
Nateglinide—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000504	0.00405	CcSEcCtD
Nateglinide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000498	0.00401	CcSEcCtD
Nateglinide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000496	0.00399	CcSEcCtD
Nateglinide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000494	0.00397	CcSEcCtD
Nateglinide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000494	0.00397	CcSEcCtD
Nateglinide—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000492	0.00396	CcSEcCtD
Nateglinide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000492	0.00395	CcSEcCtD
Nateglinide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000492	0.00395	CcSEcCtD
Nateglinide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00049	0.00394	CcSEcCtD
Nateglinide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000488	0.00392	CcSEcCtD
Nateglinide—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000468	0.00376	CcSEcCtD
Nateglinide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000462	0.00372	CcSEcCtD
Nateglinide—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000461	0.00371	CcSEcCtD
Nateglinide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000459	0.00369	CcSEcCtD
Nateglinide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000459	0.00369	CcSEcCtD
Nateglinide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.00367	CcSEcCtD
Nateglinide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000453	0.00364	CcSEcCtD
Nateglinide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00045	0.00362	CcSEcCtD
Nateglinide—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000447	0.00359	CcSEcCtD
Nateglinide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000447	0.00359	CcSEcCtD
Nateglinide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000447	0.00359	CcSEcCtD
Nateglinide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000444	0.00357	CcSEcCtD
Nateglinide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000441	0.00354	CcSEcCtD
Nateglinide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00044	0.00354	CcSEcCtD
Nateglinide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00044	0.00354	CcSEcCtD
Nateglinide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000439	0.00353	CcSEcCtD
Nateglinide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000439	0.00353	CcSEcCtD
Nateglinide—Back pain—Etoposide—peripheral nervous system neoplasm	0.000436	0.00351	CcSEcCtD
Nateglinide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000435	0.00349	CcSEcCtD
Nateglinide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00346	CcSEcCtD
Nateglinide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000429	0.00345	CcSEcCtD
Nateglinide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000426	0.00342	CcSEcCtD
Nateglinide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000426	0.00342	CcSEcCtD
Nateglinide—Enalapril—ABCB1—peripheral nervous system neoplasm	0.000423	0.0842	CrCbGaD
Nateglinide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00042	0.00338	CcSEcCtD
Nateglinide—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00338	CcSEcCtD
Nateglinide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000416	0.00334	CcSEcCtD
Nateglinide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00334	CcSEcCtD
Nateglinide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000415	0.00333	CcSEcCtD
Nateglinide—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.00332	CcSEcCtD
Nateglinide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000412	0.00331	CcSEcCtD
Nateglinide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000412	0.00331	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00327	CcSEcCtD
Nateglinide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00327	CcSEcCtD
Nateglinide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000402	0.00323	CcSEcCtD
Nateglinide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000399	0.00321	CcSEcCtD
Nateglinide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.0032	CcSEcCtD
Nateglinide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000396	0.00318	CcSEcCtD
Nateglinide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000396	0.00318	CcSEcCtD
Nateglinide—Rash—Topotecan—peripheral nervous system neoplasm	0.000396	0.00318	CcSEcCtD
Nateglinide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000395	0.00318	CcSEcCtD
Nateglinide—Cough—Etoposide—peripheral nervous system neoplasm	0.000394	0.00316	CcSEcCtD
Nateglinide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000392	0.00315	CcSEcCtD
Nateglinide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000392	0.00315	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000392	0.00315	CcSEcCtD
Nateglinide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000392	0.00315	CcSEcCtD
Nateglinide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000392	0.00315	CcSEcCtD
Nateglinide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000392	0.00315	CcSEcCtD
Nateglinide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000391	0.00314	CcSEcCtD
Nateglinide—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.00312	CcSEcCtD
Nateglinide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000389	0.00312	CcSEcCtD
Nateglinide—Rash—Melphalan—peripheral nervous system neoplasm	0.000387	0.00311	CcSEcCtD
Nateglinide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000387	0.00311	CcSEcCtD
Nateglinide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000386	0.0031	CcSEcCtD
Nateglinide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00301	CcSEcCtD
Nateglinide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.00301	CcSEcCtD
Nateglinide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000373	0.003	CcSEcCtD
Nateglinide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000373	0.003	CcSEcCtD
Nateglinide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000372	0.00299	CcSEcCtD
Nateglinide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00037	0.00297	CcSEcCtD
Nateglinide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00037	0.00297	CcSEcCtD
Nateglinide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000365	0.00293	CcSEcCtD
Nateglinide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000365	0.00293	CcSEcCtD
Nateglinide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000363	0.00292	CcSEcCtD
Nateglinide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000359	0.00289	CcSEcCtD
Nateglinide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000356	0.00286	CcSEcCtD
Nateglinide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000349	0.00281	CcSEcCtD
Nateglinide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000348	0.0028	CcSEcCtD
Nateglinide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.00279	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00279	CcSEcCtD
Nateglinide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.00272	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000337	0.00271	CcSEcCtD
Nateglinide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.0027	CcSEcCtD
Nateglinide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000335	0.00269	CcSEcCtD
Nateglinide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00268	CcSEcCtD
Nateglinide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000326	0.00262	CcSEcCtD
Nateglinide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000323	0.0026	CcSEcCtD
Nateglinide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.0026	CcSEcCtD
Nateglinide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00259	CcSEcCtD
Nateglinide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000321	0.00258	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000318	0.00255	CcSEcCtD
Nateglinide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000317	0.00255	CcSEcCtD
Nateglinide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00255	CcSEcCtD
Nateglinide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000315	0.00254	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.00251	CcSEcCtD
Nateglinide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00251	CcSEcCtD
Nateglinide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000311	0.0025	CcSEcCtD
Nateglinide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00249	CcSEcCtD
Nateglinide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000306	0.00246	CcSEcCtD
Nateglinide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000302	0.00243	CcSEcCtD
Nateglinide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000301	0.00242	CcSEcCtD
Nateglinide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000301	0.00242	CcSEcCtD
Nateglinide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00241	CcSEcCtD
Nateglinide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00239	CcSEcCtD
Nateglinide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.00239	CcSEcCtD
Nateglinide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000296	0.00238	CcSEcCtD
Nateglinide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.00236	CcSEcCtD
Nateglinide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000293	0.00235	CcSEcCtD
Nateglinide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00235	CcSEcCtD
Nateglinide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000291	0.00234	CcSEcCtD
Nateglinide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000289	0.00232	CcSEcCtD
Nateglinide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000288	0.00232	CcSEcCtD
Nateglinide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.00231	CcSEcCtD
Nateglinide—Rash—Vincristine—peripheral nervous system neoplasm	0.000287	0.0023	CcSEcCtD
Nateglinide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000286	0.0023	CcSEcCtD
Nateglinide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000286	0.0023	CcSEcCtD
Nateglinide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.00228	CcSEcCtD
Nateglinide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00225	CcSEcCtD
Nateglinide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000275	0.00221	CcSEcCtD
Nateglinide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00221	CcSEcCtD
Nateglinide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000271	0.00218	CcSEcCtD
Nateglinide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00027	0.00217	CcSEcCtD
Nateglinide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00213	CcSEcCtD
Nateglinide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000264	0.00212	CcSEcCtD
Nateglinide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00211	CcSEcCtD
Nateglinide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000261	0.00209	CcSEcCtD
Nateglinide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000256	0.00205	CcSEcCtD
Nateglinide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00204	CcSEcCtD
Nateglinide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00204	CcSEcCtD
Nateglinide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00203	CcSEcCtD
Nateglinide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00203	CcSEcCtD
Nateglinide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000252	0.00202	CcSEcCtD
Nateglinide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00197	CcSEcCtD
Nateglinide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000243	0.00196	CcSEcCtD
Nateglinide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00195	CcSEcCtD
Nateglinide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00192	CcSEcCtD
Nateglinide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000234	0.00188	CcSEcCtD
Nateglinide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00188	CcSEcCtD
Nateglinide—Rash—Etoposide—peripheral nervous system neoplasm	0.000232	0.00187	CcSEcCtD
Nateglinide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000232	0.00186	CcSEcCtD
Nateglinide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00182	CcSEcCtD
Nateglinide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000223	0.0018	CcSEcCtD
Nateglinide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00177	CcSEcCtD
Nateglinide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000219	0.00176	CcSEcCtD
Nateglinide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00166	CcSEcCtD
Nateglinide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00164	CcSEcCtD
Nateglinide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.0002	0.0016	CcSEcCtD
Nateglinide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00148	CcSEcCtD
Nateglinide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00146	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00143	CcSEcCtD
Nateglinide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00143	CcSEcCtD
Nateglinide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00136	CcSEcCtD
Nateglinide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00135	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00133	CcSEcCtD
Nateglinide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00132	CcSEcCtD
Nateglinide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00132	CcSEcCtD
Nateglinide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00131	CcSEcCtD
Nateglinide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00126	CcSEcCtD
Nateglinide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00122	CcSEcCtD
Nateglinide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00122	CcSEcCtD
Nateglinide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.00121	CcSEcCtD
Nateglinide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00119	CcSEcCtD
Nateglinide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00117	CcSEcCtD
Nateglinide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00113	CcSEcCtD
Nateglinide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00113	CcSEcCtD
Nateglinide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.0011	CcSEcCtD
Nateglinide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000136	0.0011	CcSEcCtD
Nateglinide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00109	CcSEcCtD
Nateglinide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00105	CcSEcCtD
Nateglinide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00105	CcSEcCtD
Nateglinide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00105	CcSEcCtD
Nateglinide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00104	CcSEcCtD
Nateglinide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00101	CcSEcCtD
Nateglinide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000985	CcSEcCtD
Nateglinide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000976	CcSEcCtD
Nateglinide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000968	CcSEcCtD
Nateglinide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000967	CcSEcCtD
Nateglinide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000912	CcSEcCtD
Nateglinide—SLC16A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.64e-05	0.0053	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.55e-05	0.00518	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.5e-05	0.0051	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.43e-05	0.005	CbGpPWpGaD
Nateglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.43e-05	0.005	CbGpPWpGaD
Nateglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.33e-05	0.00484	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TH—peripheral nervous system neoplasm	3.31e-05	0.00482	CbGpPWpGaD
Nateglinide—ABCC4—NRF2 pathway—HGF—peripheral nervous system neoplasm	3.3e-05	0.00481	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.3e-05	0.0048	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.19e-05	0.00464	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—MYC—peripheral nervous system neoplasm	3.1e-05	0.00452	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.06e-05	0.00446	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	2.94e-05	0.00429	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	2.9e-05	0.00423	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.9e-05	0.00422	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—HGF—peripheral nervous system neoplasm	2.86e-05	0.00416	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.85e-05	0.00415	CbGpPWpGaD
Nateglinide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.8e-05	0.00408	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	2.77e-05	0.00403	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.73e-05	0.00397	CbGpPWpGaD
Nateglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.00389	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	2.65e-05	0.00386	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.61e-05	0.0038	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.57e-05	0.00374	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.49e-05	0.00363	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.46e-05	0.00358	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	2.42e-05	0.00352	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.37e-05	0.00345	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—EED—peripheral nervous system neoplasm	2.37e-05	0.00345	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.36e-05	0.00344	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.34e-05	0.00341	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	2.3e-05	0.00336	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.27e-05	0.00331	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—peripheral nervous system neoplasm	2.15e-05	0.00313	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.12e-05	0.00309	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NCAM1—peripheral nervous system neoplasm	2.07e-05	0.00301	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.97e-05	0.00287	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—KNG1—peripheral nervous system neoplasm	1.97e-05	0.00287	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	1.94e-05	0.00283	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.94e-05	0.00282	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.91e-05	0.00278	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.89e-05	0.00276	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.86e-05	0.00271	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GNS—peripheral nervous system neoplasm	1.86e-05	0.00271	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.85e-05	0.0027	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.84e-05	0.00268	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GNS—peripheral nervous system neoplasm	1.8e-05	0.00262	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NME1—peripheral nervous system neoplasm	1.78e-05	0.00259	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.00259	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.74e-05	0.00254	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NME1—peripheral nervous system neoplasm	1.73e-05	0.00252	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—GNAS—peripheral nervous system neoplasm	1.72e-05	0.00251	CbGpPWpGaD
Nateglinide—PPARG—SREBP signalling—AKT1—peripheral nervous system neoplasm	1.71e-05	0.0025	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—COX2—peripheral nervous system neoplasm	1.71e-05	0.0025	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NME1—peripheral nervous system neoplasm	1.7e-05	0.00248	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—COX2—peripheral nervous system neoplasm	1.66e-05	0.00242	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HGF—peripheral nervous system neoplasm	1.64e-05	0.00239	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-05	0.00239	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.00236	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.58e-05	0.00231	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.58e-05	0.00231	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.56e-05	0.00227	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.53e-05	0.00223	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.53e-05	0.00223	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.52e-05	0.00222	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.49e-05	0.00217	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	1.47e-05	0.00214	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.46e-05	0.00213	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.42e-05	0.00207	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	1.41e-05	0.00206	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.4e-05	0.00204	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.38e-05	0.00201	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.38e-05	0.00201	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GNS—peripheral nervous system neoplasm	1.33e-05	0.00194	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.33e-05	0.00194	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.32e-05	0.00192	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.3e-05	0.0019	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.29e-05	0.00188	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	1.29e-05	0.00188	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	1.28e-05	0.00187	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.00186	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NME1—peripheral nervous system neoplasm	1.28e-05	0.00186	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.23e-05	0.00179	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—COX2—peripheral nervous system neoplasm	1.23e-05	0.00179	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.23e-05	0.00179	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	1.22e-05	0.00178	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.2e-05	0.00175	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.00174	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.18e-05	0.00172	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GNS—peripheral nervous system neoplasm	1.14e-05	0.00167	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-05	0.00164	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.11e-05	0.00162	CbGpPWpGaD
Nateglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	1.11e-05	0.00161	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NME1—peripheral nervous system neoplasm	1.1e-05	0.0016	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ENO2—peripheral nervous system neoplasm	1.09e-05	0.00159	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.09e-05	0.00159	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.00157	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	1.07e-05	0.00156	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.07e-05	0.00156	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—COX2—peripheral nervous system neoplasm	1.06e-05	0.00154	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.01e-05	0.00148	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1e-05	0.00146	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MET—peripheral nervous system neoplasm	9.88e-06	0.00144	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.67e-06	0.00141	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	9.62e-06	0.0014	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.62e-06	0.0014	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—BCHE—peripheral nervous system neoplasm	9.51e-06	0.00139	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.49e-06	0.00138	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	9.47e-06	0.00138	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	9.33e-06	0.00136	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	9.23e-06	0.00134	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—BCHE—peripheral nervous system neoplasm	9.22e-06	0.00134	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.14e-06	0.00133	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.09e-06	0.00132	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.07e-06	0.00132	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TH—peripheral nervous system neoplasm	8.94e-06	0.0013	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	8.94e-06	0.0013	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.92e-06	0.0013	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	8.88e-06	0.00129	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—HRAS—peripheral nervous system neoplasm	8.86e-06	0.00129	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.8e-06	0.00128	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.67e-06	0.00126	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TH—peripheral nervous system neoplasm	8.67e-06	0.00126	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	8.63e-06	0.00126	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	8.61e-06	0.00125	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—HRAS—peripheral nervous system neoplasm	8.59e-06	0.00125	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TH—peripheral nervous system neoplasm	8.55e-06	0.00124	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.29e-06	0.00121	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	8.07e-06	0.00118	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GNAS—peripheral nervous system neoplasm	7.3e-06	0.00106	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.22e-06	0.00105	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—NRAS—peripheral nervous system neoplasm	7.19e-06	0.00105	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.16e-06	0.00104	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	7.16e-06	0.00104	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GNAS—peripheral nervous system neoplasm	7.08e-06	0.00103	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.98e-06	0.00102	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	6.96e-06	0.00101	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ABCB1—peripheral nervous system neoplasm	6.95e-06	0.00101	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ENO2—peripheral nervous system neoplasm	6.93e-06	0.00101	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.89e-06	0.001	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.85e-06	0.000997	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.84e-06	0.000997	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	6.82e-06	0.000993	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.78e-06	0.000988	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.72e-06	0.000979	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	6.67e-06	0.000971	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	6.64e-06	0.000967	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.62e-06	0.000965	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.5e-06	0.000947	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	6.42e-06	0.000935	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TH—peripheral nervous system neoplasm	6.41e-06	0.000934	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.25e-06	0.00091	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNS—peripheral nervous system neoplasm	5.99e-06	0.000873	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—BCHE—peripheral nervous system neoplasm	5.86e-06	0.000853	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	5.83e-06	0.000849	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	5.81e-06	0.000846	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NME1—peripheral nervous system neoplasm	5.74e-06	0.000837	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	5.65e-06	0.000823	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.64e-06	0.000821	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.59e-06	0.000814	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	5.53e-06	0.000806	CbGpPWpGaD
Nateglinide—ALB—Metabolism—COX2—peripheral nervous system neoplasm	5.53e-06	0.000805	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TH—peripheral nervous system neoplasm	5.51e-06	0.000802	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—peripheral nervous system neoplasm	5.5e-06	0.000801	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.5e-06	0.000801	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	5.44e-06	0.000792	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	5.36e-06	0.000781	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—peripheral nervous system neoplasm	5.26e-06	0.000766	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	5.23e-06	0.000762	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	5.13e-06	0.000748	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.03e-06	0.000732	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.95e-06	0.000721	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.93e-06	0.000718	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	4.93e-06	0.000718	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	4.9e-06	0.000714	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	4.77e-06	0.000696	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	4.74e-06	0.000691	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	4.7e-06	0.000685	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.7e-06	0.000685	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—peripheral nervous system neoplasm	4.64e-06	0.000677	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	4.63e-06	0.000675	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	4.56e-06	0.000665	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.56e-06	0.000664	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	4.53e-06	0.000659	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	4.5e-06	0.000655	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	4.49e-06	0.000654	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.47e-06	0.000652	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.41e-06	0.000643	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	4.21e-06	0.000614	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	4.1e-06	0.000597	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.03e-06	0.000588	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.02e-06	0.000586	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	3.92e-06	0.000571	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	3.78e-06	0.000551	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	3.71e-06	0.00054	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	3.66e-06	0.000534	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	3.63e-06	0.000529	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.6e-06	0.000524	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	3.56e-06	0.000519	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.55e-06	0.000517	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	3.46e-06	0.000504	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.4e-06	0.000495	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	3.35e-06	0.000488	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.23e-06	0.000471	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.1e-06	0.000452	CbGpPWpGaD
Nateglinide—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	3.07e-06	0.000447	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.04e-06	0.000443	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3e-06	0.000437	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.98e-06	0.000435	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	2.97e-06	0.000433	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.93e-06	0.000426	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TH—peripheral nervous system neoplasm	2.88e-06	0.00042	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	2.73e-06	0.000398	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.68e-06	0.000391	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	2.62e-06	0.000381	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.53e-06	0.000369	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.51e-06	0.000366	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	2.43e-06	0.000353	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.42e-06	0.000352	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.39e-06	0.000349	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.38e-06	0.000347	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.36e-06	0.000344	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	2.35e-06	0.000343	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	2.31e-06	0.000336	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—peripheral nervous system neoplasm	1.97e-06	0.000287	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-06	0.000285	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.94e-06	0.000283	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.93e-06	0.000281	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—peripheral nervous system neoplasm	1.91e-06	0.000278	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.91e-06	0.000278	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.89e-06	0.000275	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.88e-06	0.000274	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.86e-06	0.00027	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.82e-06	0.000265	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.77e-06	0.000259	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-06	0.000241	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-06	0.00023	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.57e-06	0.000228	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.56e-06	0.000227	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-06	0.000206	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-06	0.000185	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-06	0.000182	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	1.21e-06	0.000177	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.02e-06	0.000149	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	9.89e-07	0.000144	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	7.38e-07	0.000107	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	6.35e-07	9.26e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	5.25e-07	7.64e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	5.2e-07	7.58e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.43e-07	5e-05	CbGpPWpGaD
